Detalhe da pesquisa
1.
Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial.
Am J Geriatr Psychiatry
; 31(12): 1077-1087, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385898
2.
Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).
Int Psychogeriatr
; 35(11): 664-672, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066690
3.
Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
Am J Geriatr Psychiatry
; 29(1): 81-89, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565008
4.
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
Am J Geriatr Psychiatry
; 29(1): 51-62, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32461027
5.
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.
Alzheimers Dement
; 15(11): 1427-1436, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587995
6.
Alzheimer's disease and related dementias: From risk factors to disease pathogenesis.
Eur J Neurosci
; 56(9): 5337-5341, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324230
7.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
N Engl J Med
; 370(4): 322-33, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450891
8.
Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment.
Am J Geriatr Psychiatry
; 24(1): 70-80, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26525995
9.
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
Br J Clin Pharmacol
; 82(3): 784-92, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27145364
10.
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.
J Geriatr Psychiatry Neurol
; 29(2): 59-64, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26303700
11.
Point-of-care research in dementia - another arrow in our quiver?
Int Psychogeriatr
; 33(3): 199-200, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781358
12.
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation.
J Pharmacokinet Pharmacodyn
; 43(1): 99-109, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26611790
13.
Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
Am J Geriatr Psychiatry
; 23(11): 1127-33, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26238225
14.
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.
Int Psychogeriatr
; 27(1): 7-17, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311499
15.
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.
Int Psychogeriatr
; 27(12): 2059-67, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26305876
16.
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
JAMA
; 314(12): 1242-54, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26393847
17.
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
Am J Geriatr Psychiatry
; 22(1): 14-24, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24314887
18.
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
JAMA
; 311(7): 682-91, 2014 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24549548
19.
A 2023 update on the advancements in the treatment of agitation in Alzheimer's disease.
Expert Opin Pharmacother
; 24(6): 691-703, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958727
20.
Effect of online tDCS to left somatomotor cortex on neuropsychiatric symptoms among older adults at risk for dementia.
Cortex
; 159: 131-141, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623419